Navigation Links
Arthritis Trial Leads to Potential Cure for High Blood Pressure
Date:4/6/2009

An Australian company may have stumbled across a cure for high blood pressure and heart disease during a clinical trial for osteoarthritis.

Bendigo, Victoria (PRWEB) April 6, 2009 -- The Elmore Oil Company, a Bendigo based company who manufactures a topical pain relief lotion for arthritis and muscular pain, recently undertook a double blind placebo controlled trial for their flagship product, Elmore Oil.

The trial was headed by Dr. Ruth S. Sy, head Rheumatologist at the Veterans Memorial Hospital in Quezon City and co-ordinated by respected researcher, Dr. Leticia Lucero-Palma. In what could be a major breakthrough in medical science, all the patients in the trial have recorded reduced uric acid levels after being in the program for as little as 4 weeks.

The trial was set up to study the effects of Elmore Oil against a placebo, on patients aged between 45 and 90 years of age, who have been clinically diagnosed with osteoarthritis. The patients all recorded their pain levels in a detailed diary but they have also been blood tested prior to the trial and weekly thereafter.

Dr. Palma noticed a marked drop in uric acids levels in all patients, up to 50% in some cases, which has led to an excited optimism that the company may have stumbled on a potential cure for high blood pressure and heart disease, as well as debilitating diseases like gout. While it is too early to make assumptions the company is prepared to fund more research into the potential cure.

A story on the effects of the product for arthritis, as well as the uric acid discovery, was recently aired on Australias leading news program, A Current Affair, in the first week of April.

According to an article published in the Journal of the American Medical Association, high uric acid levels can definitely lead to heart disease. Doctors studied nearly 6,000 people over a 20 year period. Approximately 1,500 of the people died, mostly from heart trouble. Researchers studied the patients' uric acid levels and found that an elevated uric acid level, not quite high enough to cause gout, could lead to heart disease and even death -- and the higher the uric acid level, the greater the risk.

Elmore Oil is a simple blend of Olive Oil, Eucalyptus Oil, Tea Tree Oil and specially prepared extracts of Vanilla. The companies Managing Director, Mark Linford, says the secret behind Elmore Oil is its unique blending process.

"Elmore Oil is manufactured using a process known as Triple Maturation. It's unique to Elmore Oil and it bonds the actives in the essentials oils to the circulatory components found in Vanilla so we have a product which enters the body quickly and gets to the source of the pain and inflammation quickly."

This advantage has been the driving factor behind the products spiralling popularity with the elderly generation for arthritis pain relief, but it has also struck favour with the younger and mid age groups as a recovery product for exercise and sport. Now with the potential to be used as a preventative for conditions like high blood pressure, kidney disease, heart disease and gout, the product could be set for multi national fame.

"We are hopeful that the next phase of the trial can isolate the components that are lowering the uric acid levels and allow us to pin point the science behind this amazing revelation."

###

Read the full story at http://www.prweb.com/releases/2009/04/prweb2299834.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Living Near Major Road May Boost Rheumatoid Arthritis Risk
2. Frost & Sullivan: Rheumatoid Arthritis Therapeutics in Malaysia
3. Arthritis Treatments and Joint Pain Relief Ideas Featured on Newly Launched Arthritis Today Web Site
4. As a Result of the FDA Investigation Into TNF-Alpha Inhibitors, 30 Percent of Surveyed Rheumatologists Have Altered Their Prescription Patterns for Juvenile Idiopathic Arthritis
5. Exercise Physiologist and Celebrity Trainer Bob Greene Leads National Campaign to Showcase Osteoarthritis Pain Management Techniques and New Treatment Approaches
6. CMEFirst Presents State-of-the-Art Arthritis CME Symposium
7. BioTrends Prepares to Field ChartTrends(TM) Reports to Cover the Use of Biologic Agents in Psoriasis and Rheumatoid Arthritis
8. PetCareRx Reinforces its Range of Arthritis and Joint Care Products for Winter
9. Hip Osteoarthritis Therapy No Better Than Placebo
10. Immune cells from patients with rheumatoid arthritis have prematurely aged chromosomes
11. Arthritis hinders physical activity for adults with heart disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... , ... June 27, 2017 , ... Harbour , ... token assets on the Ethereum blockchain, has released their technical specifications . , ... there has been little systematic approach for determining which offerings will garner the greatest ...
(Date:6/27/2017)... Meadows, IL (PRWEB) , ... June 27, 2017 ... ... Society for Dermatologic Surgery Association’s SUNucate efforts, Louisiana became the sixth state ... at school. With Governor John Bel Edwards’ signature, Louisiana joins the states ...
(Date:6/27/2017)... ... ... Two residents from the Gardant-managed assisted living and memory care communities in South ... protect Medicaid funding. , The video, which was produced by the American Health Care ... Cathy Schwarz, a couple who is still able to see each other every day ...
(Date:6/27/2017)... ... 27, 2017 , ... Atmosera , a premier Microsoft ... Services . The trusted, transparent, and secure solution for the cloud enablement of ... Atmosera’s next generation services include integrated capabilities for public, private, and hybrid Azure ...
(Date:6/27/2017)... Rosemont, Ill. (PRWEB) , ... June 27, 2017 , ... ... & Conditioning Association (NBSCA) have named Javair Gillett of the Houston Rockets the NBSCA ... recipient of the award is decided by NBSCA members who vote to select the ...
Breaking Medicine News(10 mins):
(Date:5/26/2017)... -- Endo International plc (NASDAQ: ENDP ) announced today ... the Company in a fireside chat at Goldman Sachs, 38 ... 2017 at 10:40 a.m. PT / 1:40 p.m. ET. The ... Rancho Palos Verdes, CA. A live ... on the Company,s website at http://www.endo.com/investors/overview . Participants should ...
(Date:5/23/2017)... PLEASANTON, Calif. , May 23, 2017 /PRNewswire/ ... world,s most innovative medical devices for pressure ulcer ... at the American Association of Critical Care Nurses, ... Houston May 22-25. The Leaf Patient ... designed specifically for the hospital environment.  The system ...
(Date:5/18/2017)...  Two Bayer U.S. Pharmaceutical leaders received top awards ... 28 th Woman of the Year ... longstanding mission of furthering the advancement and impact of ... Cindy Powell-Steffen , senior director of brand activation and ... Libby Howe , a regional business manager for New ...
Breaking Medicine Technology: